Rising health consciousness among the global population, a rapidly graying population, and increased adoption across the pharmaceutical and animal feed industries are collectively boosting the global consumption of mixed tocopherols. In the past few years, the demand for mixed tocopherols for conditions such as Parkinson’s disease, restless leg syndrome, neurogenic problems, Huntington’s chorea, and a variety of cancers, and general wellbeing has seen a positive upward trend.
Transparency Market Research states that the global mixed tocopherol market held an opportunity worth US$2.03 bn in 2015. The market is expected to expand at a healthy 4.6% CAGR over the period between 2016 and 2024. As a result, the market will rise to a valuation of US$3.04 bn by 2024. A wide gap between the global demand and supply of mixed tocopherols and fluctuating raw material prices will hinder the market’s growth to a certain extent.
Request to view Sample Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2225
Increased Adoption in Animal Feed Industry Boost Global Demand for Mixed Tocopherols
Of the several principle applications of mixed tocopherols, the segment of animal feed is presently observing development on the most promising scale. Usage of mixed tocopherols in animal feeds accounted for the largest share of over 39% in the overall market in 2015. The animal feed application segment had a valuation of $799.0 million in 2015 and is slated to rise at a healthy 4.5% CAGR over the period between 2016 and 2024. The rising global demand for high quality meat and pork is expected to expedite the consumption of mixed tocopherols in the animal feed market in the next few years.
The global consumption of mixed tocopherols is also expected to expand at a sustainable pace across applications such as pharmaceutical, dietary supplement, vitamin fortified foods, and cosmetics. Applications of mixed tocopherols in the sector of cosmetics and vitamin fortified foods and beverages is expected to expand at a 4.8% CAGR from 2016 and 2024.
Gamma Tocopherols Take the Lead as Cancer Cases Show Alarming Rise
Of the chief varieties of tocopherols that come under the purview of the global mixed tocopherols market, including alpha, beta, gamma, and delta tocopherols, the segment of gamma tocopherols is the clear leader. The segment accounted for a nearly 38% share in the market’s 2015 revenues and is expected to exhibit a 5.2% CAGR from 2016 to 2024. The anti-inflammatory properties of gamma tocopherol grant high value to the compound in the pharmaceutical industry for the preparation of drugs for Alzheimer’s, cancer, and atherosclerosis. Especially, a worrying rise in prevalence of a variety of cancers globally, will lead to the increased global consumption of gamma tocopherols in the next few years.
Request for Customization: https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=2225
Asia Pacific Surges Ahead in Mixed Tocopherol Consumption
Europe and North America are presently at the forefront of the global tocopherol market, collectively accounting for a share of nearly 60% in 2015. In Europe, which was the largest regional market for mixed tocopherols with over 32% in 2015, the rapid growth of the pharmaceutical and food industries has aided the high consumption of mixed tocopherols.
However, the market for mixed tocopherols is expected to expand in Asia Pacific at the fastest pace among other key regional markets over the said period. The region will surge ahead in the global mixed tocopherol market owing to the rising consumption of a variety of tocopherols in the animal feed, cosmetics, and pharmaceutical industries. The mixed tocopherol market in the region will also benefit from the vast and easy availability of cheap raw material sources such as palm and coconut oil.
The highly consolidated global mixed tocopherols market, where the top five players held a cumulative share of over 65% in 2015, some of the most prominent vendors are BASF S.E., DSM N.V., COFCO Tech Bio Engineering, B&D Nutritional Ingredients, Inc., Advance Organic Material S.A., Archer Daniels Midlands Company, and Davos Life Science Pte Ltd.
No comments:
Post a Comment